syndrome	score	normalized_score
LEPTIN DEFICIENCY OR DYSFUNCTION	1.0	100.0
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.5090089059999999	50.90089059999999
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5	50.0
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.05154317	5.154317
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.043243755999999994	4.3243756
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.036471956	3.6471956
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.034645736	3.4645736000000005
MARSHALL-SMITH SYNDROME; MRSHSS	0.033093155	3.3093155
CLARK-BARAITSER SYNDROME	0.032895316	3.2895316
ATKIN-FLAITZ SYNDROME	0.032050721000000004	3.2050721000000006
TEMPLE SYNDROME	0.03011981	3.011981
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.029492391000000003	2.9492391000000002
PHELAN-MCDERMID SYNDROME; PHMDS	0.029492391000000003	2.9492391000000002
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.029223396000000002	2.9223396000000004
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.028307645000000003	2.8307645000000003
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.028303515999999997	2.8303515999999997
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.027873936000000002	2.7873936
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.027873936000000002	2.7873936
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.027873936000000002	2.7873936
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.027873936000000002	2.7873936
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.027463050000000003	2.7463050000000004
LOEYS-DIETZ SYNDROME 5	0.027463050000000003	2.7463050000000004
MARFAN SYNDROME; MFS	0.027463050000000003	2.7463050000000004
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.027029341000000002	2.7029341000000002
COHEN-GIBSON SYNDROME; COGIS	0.026958185000000003	2.6958185
AUTISM, SUSCEPTIBILITY TO, 18	0.026760346	2.6760346
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.026760346	2.6760346
EHLERS-DANLOS SYNDROME, TYPE VI	0.026113590000000002	2.611359
JOUBERT SYNDROME 32; JBTS32	0.026113590000000002	2.611359
GABA-TRANSAMINASE DEFICIENCY	0.025915751	2.5915751
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.025915751	2.5915751
Sotos syndrome	0.025844595	2.5844595000000004
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.025844595	2.5844595000000004
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.025	2.5
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.025	2.5
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.025	2.5
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.025	2.5
PREMATURE OVARIAN FAILURE 2B	0.025	2.5
46,XX SEX REVERSAL 1; SRXX1	0.025	2.5
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.025	2.5
46,XY SEX REVERSAL 1; SRXY1	0.025	2.5
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.025	2.5
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.025	2.5
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.025	2.5
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.025	2.5
Lipodystrophy, congenital generalized, type 1	0.025	2.5
Lipodystrophy, congenital generalized, type 2	0.025	2.5
INFANTILE SIALIC ACID STORAGE DISEASE	0.024900591	2.4900591
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.02398484	2.398484
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.02398484	2.398484
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.023787001	2.3787000999999997
COSTELLO SYNDROME; CSTLO	0.023715845	2.3715845
Diamond-Blackfan anemia 1	0.023715845	2.3715845
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.023282136	2.3282135999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.023282136	2.3282135999999998
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02287125	2.287125
KAGAMI-OGATA SYNDROME	0.022437541	2.2437541
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.022437541	2.2437541
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022366385	2.2366384999999998
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022366385	2.2366384999999998
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.022168545999999997	2.2168545999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.02152179	2.152179
YUNIS-VARON SYNDROME	0.02152179	2.152179
ROIFMAN SYNDROME; RFMN	0.02152179	2.152179
NEMALINE MYOPATHY 10	0.02152179	2.152179
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.02152179	2.152179
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.02152179	2.152179
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.02152179	2.152179
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.021323950999999997	2.1323950999999997
GAUCHER DISEASE, PERINATAL LETHAL	0.021323950999999997	2.1323950999999997
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	2.1323950999999997
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.021323950999999997	2.1323950999999997
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.021323950999999997	2.1323950999999997
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.021252794999999998	2.1252795
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	2.0408199999999996
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	2.0408199999999996
TYSHCHENKO SYNDROME	0.020408199999999998	2.0408199999999996
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	2.0408199999999996
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	2.0408199999999996
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	2.0408199999999996
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	2.0408199999999996
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	2.0408199999999996
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	2.0408199999999996
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	2.0408199999999996
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	2.0408199999999996
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	2.0408199999999996
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	2.0408199999999996
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	2.0408199999999996
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	2.0408199999999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	2.0408199999999996
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	2.0408199999999996
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.020372506000000002	2.0372506
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.020372506000000002	2.0372506
NOONAN SYNDROME 7; NS7	0.020372506000000002	2.0372506
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.020372506000000002	2.0372506
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.019961620000000003	1.9961620000000002
BOHRING-OPITZ SYNDROME	0.019527911000000002	1.9527911000000002
HEART AND BRAIN MALFORMATION SYNDROME	0.019527911000000002	1.9527911000000002
OSTEOGENESIS IMPERFECTA, TYPE X	0.018612160000000003	1.8612160000000002
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018612160000000003	1.8612160000000002
TEEBI-SHALTOUT SYNDROME; TBSH	0.01749857	1.7498570000000002
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.016700586	1.6700586
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.016700586	1.6700586
SPINOCEREBELLAR ATAXIA 47; SCA47	0.016700586	1.6700586
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.016700586	1.6700586
LATHOSTEROLOSIS	0.016700586	1.6700586
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.016700586	1.6700586
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.016700586	1.6700586
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.016700586	1.6700586
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.015855991000000003	1.5855991000000003
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.015855991	1.5855991
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.015855991	1.5855991
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.015855991	1.5855991
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.015855991	1.5855991
VAN MALDERGEM SYNDROME 2; VMLDS2	0.015784835	1.5784835000000002
VAN MALDERGEM SYNDROME 1; VMLDS1	0.015784835	1.5784835000000002
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.015784835	1.5784835000000002
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.015784835	1.5784835000000002
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.015586996	1.5586996
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.015586996	1.5586996
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01494024	1.494024
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.014742401	1.4742401
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.014742401	1.4742401
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.014742401	1.4742401
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.014742401	1.4742401
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.014671245000000001	1.4671245000000002
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.014671245000000001	1.4671245000000002
ELSAHY-WATERS SYNDROME; ESWS	0.014671245000000001	1.4671245000000002
HOLOPROSENCEPHALY 5; HPE5	0.014671245000000001	1.4671245000000002
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.014237536	1.4237536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.014237536	1.4237536
JABERI-ELAHI SYNDROME; JABELS	0.014237536	1.4237536
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.013826650000000001	1.382665
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.013826650000000001	1.382665
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.013826650000000001	1.382665
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.013826650000000001	1.382665
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.013826650000000001	1.382665
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.013826650000000001	1.382665
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.013826650000000001	1.382665
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.013392941000000002	1.3392941000000003
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.013392941	1.3392941
PRADER-WILLI SYNDROME; PWS	0.013392941	1.3392941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.013392941	1.3392941
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.013392941	1.3392941
PEHO SYNDROME; PEHO	0.013392941	1.3392941
PITT-HOPKINS SYNDROME	0.013392941	1.3392941
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.013392941	1.3392941
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.013321785000000001	1.3321785000000002
WILLIAMS-BEUREN SYNDROME; WBS	0.013321785000000001	1.3321785000000002
SCHAAF-YANG SYNDROME; SHFYNG	0.013123946000000001	1.3123946000000002
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.013123946000000001	1.3123946000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.013123946000000001	1.3123946000000002
MENTAL RETARDATION, X-LINKED 98; MRX98	0.013123946000000001	1.3123946000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.01247719	1.247719
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.01247719	1.247719
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.01247719	1.247719
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.01247719	1.247719
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.012279351	1.2279351
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.012279351	1.2279351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.012279351	1.2279351
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.012279351	1.2279351
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.012279351	1.2279351
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.012279351	1.2279351
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.012208195000000002	1.2208195000000002
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.012208195000000002	1.2208195000000002
CHROMOSOME 1P36 DELETION SYNDROME	0.011471956	1.1471956
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.011471955999999998	1.1471955999999999
ACROCALLOSAL SYNDROME; ACLS	0.011471955999999998	1.1471955999999999
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.011471955999999998	1.1471955999999999
HUNTER-MACDONALD SYNDROME	0.011363600000000001	1.1363600000000003
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.011363600000000001	1.1363600000000003
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.011363600000000001	1.1363600000000003
SECKEL SYNDROME 2; SCKL2	0.011363600000000001	1.1363600000000003
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.011363600000000001	1.1363600000000003
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.011363600000000001	1.1363600000000003
LIG4 SYNDROME	0.011363600000000001	1.1363600000000003
PEHO-LIKE SYNDROME; PEHOL	0.011363600000000001	1.1363600000000003
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.011363600000000001	1.1363600000000003
ALLAN-HERNDON-DUDLEY SYNDROME	0.011363600000000001	1.1363600000000003
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.011363600000000001	1.1363600000000003
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.011363600000000001	1.1363600000000003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.010627361	1.0627361
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.010627361	1.0627361
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.010627361	1.0627361
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.010627361	1.0627361
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.010556204999999999	1.0556204999999999
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.010556204999999999	1.0556204999999999
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.010358365999999999	1.0358365999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.010358365999999999	1.0358365999999999
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.010358365999999999	1.0358365999999999
DYSOSTEOSCLEROSIS	0.010358365999999999	1.0358365999999999
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.009711609999999999	0.9711609999999999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.009711609999999999	0.9711609999999999
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.009711609999999999	0.9711609999999999
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.009513771	0.9513771000000001
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.009513771	0.9513771000000001
CEREBROOCULONASAL SYNDROME	0.009442615	0.9442615
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.009442615	0.9442615
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.009442615	0.9442615
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.009008906	0.9008906000000001
Helsmoortel-van der Aa syndrome	0.009008905999999999	0.9008905999999999
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.009008905999999999	0.9008905999999999
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.009008905999999999	0.9008905999999999
LUSCAN-LUMISH SYNDROME; LLS	0.009008905999999999	0.9008905999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.009008905999999999	0.9008905999999999
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.009008905999999999	0.9008905999999999
ZUNICH NEUROECTODERMAL SYNDROME	0.009008905999999999	0.9008905999999999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.009008905999999999	0.9008905999999999
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009008905999999999	0.9008905999999999
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.009008905999999999	0.9008905999999999
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.009008905999999999	0.9008905999999999
OGDEN SYNDROME; OGDNS	0.00859802	0.859802
FRANK-TER HAAR SYNDROME; FTHS	0.00859802	0.859802
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00859802	0.859802
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00859802	0.859802
NASODIGITOACOUSTIC SYNDROME	0.00859802	0.859802
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00859802	0.859802
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00859802	0.859802
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.008164311	0.8164311000000001
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.008164311	0.8164311000000001
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008164311	0.8164311000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.008164311	0.8164311000000001
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.008164311	0.8164311000000001
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.008164311	0.8164311000000001
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.008164311	0.8164311000000001
PETTIGREW SYNDROME	0.008164311	0.8164311000000001
DESANTO-SHINAWI SYNDROME	0.008164311	0.8164311000000001
PALLISTER-KILLIAN SYNDROME	0.008164311	0.8164311000000001
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.008164311	0.8164311000000001
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.008093155	0.8093155
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.008093155	0.8093155
MENTAL RETARDATION, X-LINKED 99	0.008093155	0.8093155
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.008093155	0.8093155
COFFIN-SIRIS SYNDROME 7; CSS7	0.008093155	0.8093155
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.008093155	0.8093155
MENTAL RETARDATION, X-LINKED 19	0.008093155	0.8093155
JOUBERT SYNDROME 1	0.008093155	0.8093155
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.008093155	0.8093155
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.008093155	0.8093155
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.007895316	0.7895315999999999
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.007895316	0.7895315999999999
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.007895316	0.7895315999999999
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.007895316	0.7895315999999999
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.007895316	0.7895315999999999
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.007895316	0.7895315999999999
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.007895316	0.7895315999999999
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.007895316	0.7895315999999999
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00724856	0.7248560000000001
LARSEN-LIKE SYNDROME	0.00724856	0.7248560000000001
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00724856	0.7248560000000001
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00724856	0.7248560000000001
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00724856	0.7248560000000001
MENTAL RETARDATION, X-LINKED 93	0.00724856	0.7248560000000001
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.00724856	0.7248560000000001
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00724856	0.7248560000000001
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.00724856	0.7248560000000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00724856	0.7248560000000001
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00724856	0.7248560000000001
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00724856	0.7248560000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00724856	0.7248560000000001
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.00724856	0.7248560000000001
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00724856	0.7248560000000001
PETERS-PLUS SYNDROME; PTRPLS	0.007050721	0.7050721
GRACILE BONE DYSPLASIA; GCLEB	0.007050721	0.7050721
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.007050721	0.7050721
WEBB-DATTANI SYNDROME; WEDAS	0.007050721	0.7050721
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.007050721	0.7050721
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.007050721	0.7050721
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.007050721	0.7050721
NOONAN SYNDROME 5; NS5	0.006979565	0.6979565
METAPHYSEAL ACROSCYPHODYSPLASIA	0.006979565	0.6979565
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.006979565	0.6979565
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.006979565	0.6979565
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.006979565	0.6979565
KEIPERT SYNDROME; KPTS	0.006979565	0.6979565
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.006979565	0.6979565
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.006979565	0.6979565
#150250 LARSEN SYNDROME; LRS	0.006979565	0.6979565
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.006979565	0.6979565
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.006979565	0.6979565
PELGER-HUET ANOMALY; PHA	0.006979565	0.6979565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.006979565	0.6979565
ZECHI-CEIDE SYNDROME	0.006979565	0.6979565
SHORT SYNDROME	0.00613497	0.613497
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00613497	0.613497
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00613497	0.613497
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00613497	0.613497
FG SYNDROME 2; FGS2	0.00613497	0.613497
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00613497	0.613497
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00613497	0.613497
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00613497	0.613497
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00613497	0.613497
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00613497	0.613497
CRANIOSYNOSTOSIS 4; CRS4	0.00613497	0.613497
TRICHOHEPATOENTERIC SYNDROME 1	0.00613497	0.613497
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00613497	0.613497
HYPERTELORISM, TEEBI TYPE; TBHS	0.00613497	0.613497
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00613497	0.613497
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00613497	0.613497
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00613497	0.613497
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.00613497	0.613497
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00613497	0.613497
SAUL-WILSON SYNDROME; SWILS	0.00613497	0.613497
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00613497	0.613497
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00613497	0.613497
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00613497	0.613497
#170100 PROLIDASE DEFICIENCY	0.00613497	0.613497
ODONTOCHONDRODYSPLASIA; ODCD	0.00613497	0.613497
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00613497	0.613497
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.00613497	0.613497
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00613497	0.613497
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00613497	0.613497
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00613497	0.613497
268650 RUDIGER SYNDROME	0.00613497	0.613497
STEEL SYNDROME; STLS	0.00613497	0.613497
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00613497	0.613497
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00613497	0.613497
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00613497	0.613497
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.00613497	0.613497
TRICHOHEPATOENTERIC SYNDROME 2	0.00613497	0.613497
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00613497	0.613497
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.005336986	0.5336986
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.005336986	0.5336986
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005336986	0.5336986
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.005336986	0.5336986
MARDEN-WALKER SYNDROME	0.005336986	0.5336986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.005336986	0.5336986
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.005336986	0.5336986
KOOLEN-DE VRIES SYNDROME; KDVS	0.005336986	0.5336986
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.005336986	0.5336986
COFFIN-LOWRY SYNDROME; CLS	0.005336986	0.5336986
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.005336986	0.5336986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005336986	0.5336986
KABUKI SYNDROME 1	0.005336986	0.5336986
MENTAL RETARDATION, X-LINKED 90	0.005336986	0.5336986
WIEDEMANN-STEINER SYNDROME; WDSTS	0.005336986	0.5336986
EMANUEL SYNDROME	0.005336986	0.5336986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.005336986	0.5336986
#300867 KABUKI SYNDROME 2; KABUK2	0.005336986	0.5336986
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.005336986	0.5336986
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.005336986	0.5336986
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.005336986	0.5336986
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.005336986	0.5336986
ZTTK SYNDROME; ZTTKS	0.005336986	0.5336986
MEND SYNDROME; MEND	0.005336986	0.5336986
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.005336986	0.5336986
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.005336986	0.5336986
WITTEVEEN-KOLK SYNDROME	0.005336986	0.5336986
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.005336986	0.5336986
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.005336986	0.5336986
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.005336986	0.5336986
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.004492391	0.4492391
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.004492391	0.4492391
ZIMMERMANN-LABAND SYNDROME 1	0.004492391	0.4492391
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.004492391	0.4492391
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.004492391	0.4492391
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004492391	0.4492391
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.004492391	0.4492391
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.004492391	0.4492391
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.004492391	0.4492391
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004492391	0.4492391
POTOCKI-LUPSKI SYNDROME	0.004492391	0.4492391
WIEACKER-WOLFF SYNDROME	0.004492391	0.4492391
C SYNDROME	0.004492391	0.4492391
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004492391	0.4492391
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.004492391	0.4492391
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004492391	0.4492391
LISSENCEPHALY, X-LINKED, 2	0.004492391	0.4492391
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.004421235	0.4421235
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004421235	0.4421235
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.004421235	0.4421235
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.004421235	0.4421235
OROFACIODIGITAL SYNDROME VI	0.004421235	0.4421235
WHITE-SUTTON SYNDROME; WHSUS	0.004421235	0.4421235
JOUBERT SYNDROME 2	0.004421235	0.4421235
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.004421235	0.4421235
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004421235	0.4421235
WARSAW BREAKAGE SYNDROME; WABS	0.004421235	0.4421235
IMMUNODEFICIENCY 23; IMD23	0.004421235	0.4421235
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.004421235	0.4421235
HADZISELIMOVIC SYNDROME	0.004421235	0.4421235
RING CHROMOSOME 14 SYNDROME	0.004421235	0.4421235
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004421235	0.4421235
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.004421235	0.4421235
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.004421235	0.4421235
AU-KLINE SYNDROME; AUKS	0.004421235	0.4421235
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.004421235	0.4421235
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.004421235	0.4421235
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.004421235	0.4421235
DUBOWITZ SYNDROME	0.004421235	0.4421235
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.004421235	0.4421235
ARTERIAL TORTUOSITY SYNDROME	0.004421235	0.4421235
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.004223396	0.4223396
COWDEN SYNDROME 6; CWS6	0.004223396	0.4223396
CORNELIA DE LANGE SYNDROME 3	0.004223396	0.4223396
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.004223396	0.4223396
SECKEL SYNDROME 1; SCKL1	0.004223396	0.4223396
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.004223396	0.4223396
RENPENNING SYNDROME 1; RENS1	0.004223396	0.4223396
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.004223396	0.4223396
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.004223396	0.4223396
COWDEN SYNDROME 5; CWS5	0.004223396	0.4223396
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004223396	0.4223396
2q33.1 deletion syndrome	0.004223396	0.4223396
Muenke syndrome	0.004223396	0.4223396
CHROMOSOME 1p35 DELETION SYNDROME	0.004223396	0.4223396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004223396	0.4223396
CORNELIA DE LANGE SYNDROME 1	0.004223396	0.4223396
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004223396	0.4223396
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004223396	0.4223396
COFFIN-SIRIS SYNDROME 1; CSS1	0.004223396	0.4223396
MENTAL RETARDATION, X-LINKED 104; MRX104	0.004223396	0.4223396
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.004223396	0.4223396
OROFACIODIGITAL SYNDROME I; OFD1	0.004223396	0.4223396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.004223396	0.4223396
GLASS SYNDROME	0.004223396	0.4223396
CHROMOSOME 16p13.3 DELETION SYNDROME	0.004223396	0.4223396
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.004223396	0.4223396
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00357664	0.357664
LATERAL MENINGOCELE SYNDROME	0.00357664	0.357664
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.00357664	0.357664
LEGIUS SYNDROME	0.00357664	0.357664
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00357664	0.357664
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00357664	0.357664
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00357664	0.357664
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00357664	0.357664
ADDUCTED THUMBS SYNDROME	0.00357664	0.357664
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00357664	0.357664
FUMARASE DEFICIENCY; FMRD	0.00357664	0.357664
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00357664	0.357664
NEMALINE MYOPATHY 7; NEM7	0.00357664	0.357664
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00357664	0.357664
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00357664	0.357664
TARP SYNDROME; TARPS	0.00357664	0.357664
NEMALINE MYOPATHY 4	0.00357664	0.357664
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00357664	0.357664
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00357664	0.357664
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00357664	0.357664
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00357664	0.357664
MYOPATHY, CENTRONUCLEAR, 5	0.00357664	0.357664
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00357664	0.357664
CHROMOSOME 16Q22 DELETION SYNDROME	0.00357664	0.357664
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00357664	0.357664
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00357664	0.357664
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00357664	0.357664
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00357664	0.357664
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00357664	0.357664
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00357664	0.357664
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00357664	0.357664
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00357664	0.357664
HYPEREKPLEXIA 4; HKPX4	0.003378801	0.33788009999999996
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003378801	0.33788009999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003378801	0.33788009999999996
DIGEORGE SYNDROME; DGS	0.003378801	0.33788009999999996
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.003378801	0.33788009999999996
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.003378801	0.33788009999999996
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.003378801	0.33788009999999996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.003378801	0.33788009999999996
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.003378801	0.33788009999999996
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.003378801	0.33788009999999996
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.003378801	0.33788009999999996
CATEL-MANZKE SYNDROME; CATMANS	0.003378801	0.33788009999999996
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.003378801	0.33788009999999996
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.003378801	0.33788009999999996
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.003378801	0.33788009999999996
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.003378801	0.33788009999999996
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.003378801	0.33788009999999996
MENTAL RETARDATION, X-LINKED 91; MRX91	0.003378801	0.33788009999999996
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.003378801	0.33788009999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.003378801	0.33788009999999996
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.003378801	0.33788009999999996
PERRAULT SYNDROME 5; PRLTS5	0.003378801	0.33788009999999996
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.003378801	0.33788009999999996
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.003378801	0.33788009999999996
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.003378801	0.33788009999999996
TURNPENNY-FRY SYNDROME; TPFS	0.003307645	0.3307645
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.003307645	0.3307645
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.003307645	0.3307645
MENTAL RETARDATION, BUENOS AIRES TYPE	0.003307645	0.3307645
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.003307645	0.3307645
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.003307645	0.3307645
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.003307645	0.3307645
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.003307645	0.3307645
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.003307645	0.3307645
FEINGOLD SYNDROME 1; FGLDS1	0.003307645	0.3307645
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.003307645	0.3307645
MEIER-GORLIN SYNDROME 1; MGORS1	0.003307645	0.3307645
SECKEL SYNDROME 5; SCKL5	0.003307645	0.3307645
15q26 overgrowth syndrome	0.003307645	0.3307645
601095 HARROD SYNDROME	0.003307645	0.3307645
KENNERKNECHT SYNDROME	0.003307645	0.3307645
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.003307645	0.3307645
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.003307645	0.3307645
MENTAL RETARDATION, X-LINKED 2	0.003307645	0.3307645
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.003307645	0.3307645
FRONTOMETAPHYSEAL DYSPLASIA	0.003307645	0.3307645
CHROMOSOME 17q12 DELETION SYNDROME	0.003307645	0.3307645
#278250 WRINKLY SKIN SYNDROME; WSS	0.003307645	0.3307645
CRI-DU-CHAT SYNDROME	0.003307645	0.3307645
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.003307645	0.3307645
ALAZAMI-YUAN SYNDROME	0.003307645	0.3307645
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.003307645	0.3307645
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.003307645	0.3307645
MENTAL RETARDATION, X-LINKED 45	0.003307645	0.3307645
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.003307645	0.3307645
ROBERTS SYNDROME; RBS	0.003307645	0.3307645
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.003307645	0.3307645
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.003307645	0.3307645
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.003307645	0.3307645
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.003307645	0.3307645
CHROMOSOME 18P DELETION SYNDROME	0.003307645	0.3307645
BARDET-BIEDL SYNDROME 1; BBS1	0.003307645	0.3307645
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.003307645	0.3307645
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.003307645	0.3307645
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.003307645	0.3307645
HALLERMANN-STREIFF SYNDROME; HSS	0.003307645	0.3307645
MENKES DISEASE	0.002873936	0.2873936
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.002873936	0.2873936
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002873936	0.2873936
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.002873936	0.2873936
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.002873936	0.2873936
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.002873936	0.2873936
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002873936	0.2873936
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002873936	0.2873936
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.002873936	0.2873936
GLYCINE ENCEPHALOPATHY; GCE	0.002873936	0.2873936
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002873936	0.2873936
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002873936	0.2873936
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002873936	0.2873936
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.002873936	0.2873936
MENTAL RETARDATION, X-LINKED 1	0.002873936	0.2873936
SALLA DISEASE	0.002873936	0.2873936
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.002873936	0.2873936
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.002873936	0.2873936
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002873936	0.2873936
ELEJALDE DISEASE	0.002873936	0.2873936
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002873936	0.2873936
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002873936	0.2873936
KLEEFSTRA SYNDROME 2; KLEFS2	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002873936	0.2873936
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002873936	0.2873936
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002873936	0.2873936
XQ25 DUPLICATION SYNDROME	0.002873936	0.2873936
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.002873936	0.2873936
PYRUVATE CARBOXYLASE DEFICIENCY	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002873936	0.2873936
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.002873936	0.2873936
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002873936	0.2873936
JOUBERT SYNDROME 30; JBTS30	0.002873936	0.2873936
MENTAL RETARDATION, X-LINKED 102	0.002873936	0.2873936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.002873936	0.2873936
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002873936	0.2873936
KETOADIPICACIDURIA	0.002873936	0.2873936
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.002873936	0.2873936
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.002873936	0.2873936
HYPERPROLINEMIA, TYPE I	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002873936	0.2873936
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.002873936	0.2873936
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002873936	0.2873936
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.002873936	0.2873936
MAPLE SYRUP URINE DISEASE; MSUD	0.002873936	0.2873936
GRISCELLI SYNDROME, TYPE 1	0.002873936	0.2873936
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002873936	0.2873936
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002873936	0.2873936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002873936	0.2873936
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0028739359999999997	0.28739359999999997
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0028739359999999997	0.28739359999999997
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0028739359999999997	0.28739359999999997
PELIZAEUS-MERZBACHER DISEASE	0.0028739359999999997	0.28739359999999997
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0028739359999999997	0.28739359999999997
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.0028739359999999997	0.28739359999999997
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.0028739359999999997	0.28739359999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0028739359999999997	0.28739359999999997
TIMOTHY SYNDROME; TS	0.0028739359999999997	0.28739359999999997
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.0028739359999999997	0.28739359999999997
NEURAMINIDASE DEFICIENCY	0.0028739359999999997	0.28739359999999997
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0028739359999999997	0.28739359999999997
NIEMANN-PICK DISEASE, TYPE C2	0.0028739359999999997	0.28739359999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0028739359999999997	0.28739359999999997
COFFIN-SIRIS SYNDROME 4; CSS4	0.0028739359999999997	0.28739359999999997
CHROMOSOME 16p13.2 DELETION SYNDROME	0.0028739359999999997	0.28739359999999997
METACHROMATIC LEUKODYSTROPHY	0.0028739359999999997	0.28739359999999997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0028739359999999997	0.28739359999999997
SMITH-MAGENIS SYNDROME; SMS	0.0028739359999999997	0.28739359999999997
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0028739359999999997	0.28739359999999997
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0028739359999999997	0.28739359999999997
CYCLIC VOMITING SYNDROME	0.0028739359999999997	0.28739359999999997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0028739359999999997	0.28739359999999997
WEAVER SYNDROME	0.0028739359999999997	0.28739359999999997
SHASHI-PENA SYNDROME; SHAPNS	0.0028739359999999997	0.28739359999999997
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0028739359999999997	0.28739359999999997
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0028739359999999997	0.28739359999999997
CHROMOSOME 18Q DELETION SYNDROME	0.0028739359999999997	0.28739359999999997
COHEN SYNDROME	0.0028739359999999997	0.28739359999999997
CHROMOSOME 5Q12 DELETION SYNDROME	0.0028739359999999997	0.28739359999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0028739359999999997	0.28739359999999997
HOLOPROSENCEPHALY 2; HPE2	0.0028739359999999997	0.28739359999999997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0028739359999999997	0.28739359999999997
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0028739359999999997	0.28739359999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0028739359999999997	0.28739359999999997
CHROMOSOME 10Q26 DELETION SYNDROME	0.0028739359999999997	0.28739359999999997
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0028739359999999997	0.28739359999999997
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0028739359999999997	0.28739359999999997
IMMUNODEFICIENCY 49; IMD49	0.0028739359999999997	0.28739359999999997
ADENYLOSUCCINASE DEFICIENCY	0.0028739359999999997	0.28739359999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0028739359999999997	0.28739359999999997
FOLATE MALABSORPTION, HEREDITARY	0.0028739359999999997	0.28739359999999997
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028739359999999997	0.28739359999999997
Pontine tegmental cap dysplasia	0.0028739359999999997	0.28739359999999997
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.0028739359999999997	0.28739359999999997
OHDO SYNDROME	0.0028739359999999997	0.28739359999999997
AL KAISSI SYNDROME; ALKAS	0.0028739359999999997	0.28739359999999997
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0028739359999999997	0.28739359999999997
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0028739359999999997	0.28739359999999997
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0028739359999999997	0.28739359999999997
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0028739359999999997	0.28739359999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0028739359999999997	0.28739359999999997
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0028739359999999997	0.28739359999999997
LISSENCEPHALY 5; LIS5	0.0028739359999999997	0.28739359999999997
CODAS SYNDROME	0.0028739359999999997	0.28739359999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0028739359999999997	0.28739359999999997
LEIGH SYNDROME; LS	0.0028739359999999997	0.28739359999999997
COFFIN-SIRIS SYNDROME 3; CSS3	0.0028739359999999997	0.28739359999999997
ADAMS-OLIVER SYNDROME 1; AOS1	0.0028739359999999997	0.28739359999999997
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0028739359999999997	0.28739359999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0028739359999999997	0.28739359999999997
AICARDI-GOUTIERES SYNDROME 7	0.0028739359999999997	0.28739359999999997
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0028739359999999997	0.28739359999999997
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0028739359999999997	0.28739359999999997
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0028739359999999997	0.28739359999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0028739359999999997	0.28739359999999997
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0028739359999999997	0.28739359999999997
TENORIO SYNDROME; TNORS	0.0028739359999999997	0.28739359999999997
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0028739359999999997	0.28739359999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0028739359999999997	0.28739359999999997
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0028739359999999997	0.28739359999999997
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0028739359999999997	0.28739359999999997
ASPARTYLGLUCOSAMINURIA; AGU	0.0028739359999999997	0.28739359999999997
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0028739359999999997	0.28739359999999997
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0028739359999999997	0.28739359999999997
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0028739359999999997	0.28739359999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0028739359999999997	0.28739359999999997
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0028739359999999997	0.28739359999999997
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0028739359999999997	0.28739359999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.0028739359999999997	0.28739359999999997
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0028739359999999997	0.28739359999999997
HOLOPROSENCEPHALY 1; HPE1	0.0028739359999999997	0.28739359999999997
MICROPHTHALMIA, SYNDROMIC 1	0.0028739359999999997	0.28739359999999997
COFFIN-SIRIS SYNDROME 2; CSS2	0.0028739359999999997	0.28739359999999997
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0028739359999999997	0.28739359999999997
SMITH-KINGSMORE SYNDROME; SKS	0.0028739359999999997	0.28739359999999997
MEHMO SYNDROME; MEHMO	0.0028739359999999997	0.28739359999999997
ACRORENAL-MANDIBULAR SYNDROME	0.00246305	0.246305
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00246305	0.246305
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00246305	0.246305
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.00246305	0.246305
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00246305	0.246305
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.00246305	0.246305
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00246305	0.246305
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00246305	0.246305
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00246305	0.246305
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00246305	0.246305
LOEYS-DIETZ SYNDROME 3; LDS3	0.00246305	0.246305
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00246305	0.246305
EVEN-PLUS SYNDROME	0.00246305	0.246305
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00246305	0.246305
#614976 CARPENTER SYNDROME 2; CRPT2	0.00246305	0.246305
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00246305	0.246305
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00246305	0.246305
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00246305	0.246305
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00246305	0.246305
#613611 CHOANAL ATRESIA AND LYMPHEDEMA	0.00246305	0.246305
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00246305	0.246305
CRANIOECTODERMAL DYSPLASIA 1	0.00246305	0.246305
NEMALINE MYOPATHY 1; NEM1	0.00246305	0.246305
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00246305	0.246305
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00246305	0.246305
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00246305	0.246305
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.00246305	0.246305
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00246305	0.246305
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00246305	0.246305
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.00246305	0.246305
LERI-WEILL DYSCHONDROSTEOSIS	0.00246305	0.246305
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00246305	0.246305
HYPOGLOSSIA WITH SITUS INVERSUS	0.00246305	0.246305
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00246305	0.246305
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00246305	0.246305
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00246305	0.246305
HAMAMY SYNDROME; HMMS	0.00246305	0.246305
NEU-LAXOVA SYNDROME 2; NLS2	0.00246305	0.246305
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00246305	0.246305
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00246305	0.246305
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.00246305	0.246305
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00246305	0.246305
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00246305	0.246305
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00246305	0.246305
NEMALINE MYOPATHY 2; NEM2	0.00246305	0.246305
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00246305	0.246305
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00246305	0.246305
#615731 NEMALINE MYOPATHY 9; NEM9	0.00246305	0.246305
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00246305	0.246305
Ullrich congenital muscular dystrophy 1	0.00246305	0.246305
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00246305	0.246305
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00246305	0.246305
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00246305	0.246305
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00246305	0.246305
MACS SYNDROME	0.00246305	0.246305
OROFACIODIGITAL SYNDROME IV; OFD4	0.00246305	0.246305
RAINE SYNDROME	0.00246305	0.246305
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00246305	0.246305
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00246305	0.246305
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00246305	0.246305
OROFACIODIGITAL SYNDROME IX; OFD9	0.00246305	0.246305
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00246305	0.246305
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00246305	0.246305
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00246305	0.246305
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00246305	0.246305
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00246305	0.246305
MARTSOLF SYNDROME	0.00246305	0.246305
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00246305	0.246305
MYOPATHY, DISTAL, 1; MPD1	0.00246305	0.246305
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00246305	0.246305
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00246305	0.246305
THREE M SYNDROME 2; 3M2	0.00246305	0.246305
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00246305	0.246305
BRANCHIOOTORENAL SYNDROME 1	0.00246305	0.246305
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00246305	0.246305
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00246305	0.246305
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00246305	0.246305
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00246305	0.246305
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00246305	0.246305
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00246305	0.246305
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00246305	0.246305
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.00246305	0.246305
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00246305	0.246305
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.00246305	0.246305
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00246305	0.246305
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00246305	0.246305
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00246305	0.246305
Contractural arachnodactyly, congenital	0.00246305	0.246305
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.00246305	0.246305
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00246305	0.246305
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00246305	0.246305
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00246305	0.246305
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00246305	0.246305
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00246305	0.246305
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00246305	0.246305
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00246305	0.246305
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.00246305	0.246305
MARFANOID HYPERMOBILITY SYNDROME	0.00246305	0.246305
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00246305	0.246305
FRONTOOCULAR SYNDROME	0.00246305	0.246305
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00246305	0.246305
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00246305	0.246305
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00246305	0.246305
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00246305	0.246305
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00246305	0.246305
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.00246305	0.246305
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00246305	0.246305
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.00246305	0.246305
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00246305	0.246305
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.00246305	0.246305
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00246305	0.246305
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00246305	0.246305
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00246305	0.246305
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00246305	0.246305
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00246305	0.246305
MOEBIUS SYNDROME; MBS	0.00246305	0.246305
MEIER-GORLIN SYNDROME 7	0.00246305	0.246305
NEMALINE MYOPATHY 3; NEM3	0.00246305	0.246305
RAPADILINO SYNDROME	0.00246305	0.246305
NOONAN SYNDROME 3; NS3	0.00246305	0.246305
608028 THAI SYMPHALANGISM SYNDROME	0.00246305	0.246305
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00246305	0.246305
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00246305	0.246305
SWEENEY-COX SYNDROME; SWCOS	0.00246305	0.246305
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00246305	0.246305
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00246305	0.246305
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.00246305	0.246305
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.00246305	0.246305
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00246305	0.246305
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.002029341	0.2029341
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.002029341	0.2029341
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002029341	0.2029341
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002029341	0.2029341
Glycosylphosphatidylinositol biosynthesis defect 18	0.002029341	0.2029341
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002029341	0.2029341
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.002029341	0.2029341
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.002029341	0.2029341
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.002029341	0.2029341
SHUKLA-VERNON SYNDROME; SHUVER	0.002029341	0.2029341
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002029341	0.2029341
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.002029341	0.2029341
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.002029341	0.2029341
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002029341	0.2029341
HYPOPHOSPHATASIA, INFANTILE	0.002029341	0.2029341
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002029341	0.2029341
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.002029341	0.2029341
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.002029341	0.2029341
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.002029341	0.2029341
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.002029341	0.2029341
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.002029341	0.2029341
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.002029341	0.2029341
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.002029341	0.2029341
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.002029341	0.2029341
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.002029341	0.2029341
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.002029341	0.2029341
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.002029341	0.2029341
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.002029341	0.2029341
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.002029341	0.2029341
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.002029341	0.2029341
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.002029341	0.2029341
ADAMS-OLIVER SYNDROME 2; AOS2	0.002029341	0.2029341
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002029341	0.2029341
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002029341	0.2029341
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.002029341	0.2029341
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.002029341	0.2029341
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.002029341	0.2029341
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.002029341	0.2029341
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.002029341	0.2029341
SCHINDLER DISEASE, TYPE I	0.002029341	0.2029341
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002029341	0.2029341
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.002029341	0.2029341
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.002029341	0.2029341
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.002029341	0.2029341
N-ACETYLASPARTATE DEFICIENCY; NACED	0.002029341	0.2029341
METHYLMALONIC ACIDURIA, CBLA TYPE	0.002029341	0.2029341
MOWAT-WILSON SYNDROME; MOWS	0.002029341	0.2029341
KLEEFSTRA SYNDROME	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.002029341	0.2029341
RAYNAUD-CLAES SYNDROME; MRXSRC	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.002029341	0.2029341
GLUTARIC ACIDEMIA I; GA1	0.002029341	0.2029341
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.002029341	0.2029341
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.002029341	0.2029341
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.002029341	0.2029341
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.002029341	0.2029341
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002029341	0.2029341
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.002029341	0.2029341
COACH SYNDROME	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.002029341	0.2029341
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.002029341	0.2029341
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.002029341	0.2029341
GLUTAMINE DEFICIENCY, CONGENITAL	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.002029341	0.2029341
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.002029341	0.2029341
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.002029341	0.2029341
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002029341	0.2029341
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002029341	0.2029341
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.002029341	0.2029341
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.002029341	0.2029341
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002029341	0.2029341
SULFOCYSTEINURIA	0.002029341	0.2029341
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.002029341	0.2029341
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.002029341	0.2029341
TEMTAMY SYNDROME; TEMTYS	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.002029341	0.2029341
INFANTILE LIVER FAILURE SYNDROME 1	0.002029341	0.2029341
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.002029341	0.2029341
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002029341	0.2029341
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.002029341	0.2029341
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.002029341	0.2029341
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002029341	0.2029341
VISCERAL STEATOSIS, CONGENITAL	0.002029341	0.2029341
VICI SYNDROME; VICIS	0.002029341	0.2029341
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.002029341	0.2029341
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.002029341	0.2029341
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.002029341	0.2029341
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002029341	0.2029341
GM2-GANGLIOSIDOSIS, AB VARIANT	0.002029341	0.2029341
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.002029341	0.2029341
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.002029341	0.2029341
XYLOSIDASE DEFICIENCY	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.002029341	0.2029341
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.002029341	0.2029341
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002029341	0.2029341
TAY-SACHS DISEASE; TSD	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.002029341	0.2029341
LISSENCEPHALY 3; LIS3	0.002029341	0.2029341
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.002029341	0.2029341
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002029341	0.2029341
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.002029341	0.2029341
COFFIN-SIRIS SYNDROME 8; CSS8	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.002029341	0.2029341
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002029341	0.2029341
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002029341	0.2029341
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002029341	0.2029341
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.002029341	0.2029341
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.002029341	0.2029341
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002029341	0.2029341
ANGELMAN SYNDROME	0.002029341	0.2029341
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.002029341	0.2029341
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.002029341	0.2029341
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002029341	0.2029341
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.002029341	0.2029341
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.002029341	0.2029341
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002029341	0.2029341
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002029341	0.2029341
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002029341	0.2029341
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002029341	0.2029341
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.002029341	0.2029341
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.002029341	0.2029341
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002029341	0.2029341
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.002029341	0.2029341
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.002029341	0.2029341
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.002029341	0.2029341
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.002029341	0.2029341
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002029341	0.2029341
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.002029341	0.2029341
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002029341	0.2029341
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.002029341	0.2029341
PSEUDO-TORCH SYNDROME 2	0.002029341	0.2029341
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.002029341	0.2029341
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.002029341	0.2029341
SUDDEN CARDIAC FAILURE, INFANTILE	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002029341	0.2029341
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002029341	0.2029341
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002029341	0.2029341
EPISODIC ATAXIA, TYPE 6	0.002029341	0.2029341
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002029341	0.2029341
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.001958185	0.19581849999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001958185	0.19581849999999998
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001958185	0.19581849999999998
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.001958185	0.19581849999999998
LAMB-SHAFFER SYNDROME	0.001958185	0.19581849999999998
MARINESCO-SJOGREN SYNDROME; MSS	0.001958185	0.19581849999999998
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.001958185	0.19581849999999998
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001958185	0.19581849999999998
JOUBERT SYNDROME 15	0.001958185	0.19581849999999998
HYPERCALCEMIA, INFANTILE, 1	0.001958185	0.19581849999999998
COFFIN-SIRIS SYNDROME 6; CSS6	0.001958185	0.19581849999999998
MENTAL RETARDATION, X-LINKED 41	0.001958185	0.19581849999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001958185	0.19581849999999998
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.001958185	0.19581849999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001958185	0.19581849999999998
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.001958185	0.19581849999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001958185	0.19581849999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.001958185	0.19581849999999998
JOUBERT SYNDROME 3; JBTS3	0.001958185	0.19581849999999998
JOUBERT SYNDROME 6	0.001958185	0.19581849999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001958185	0.19581849999999998
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001958185	0.19581849999999998
XIA-GIBBS SYNDROME	0.001958185	0.19581849999999998
JOUBERT SYNDROME 8	0.001958185	0.19581849999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001958185	0.19581849999999998
COFFIN-SIRIS SYNDROME 10; CSS10	0.001958185	0.19581849999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001958185	0.19581849999999998
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.001958185	0.19581849999999998
MENTAL RETARDATION, X-LINKED 12; MRX12	0.001958185	0.19581849999999998
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.001958185	0.19581849999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001958185	0.19581849999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.001958185	0.19581849999999998
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.001958185	0.19581849999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001958185	0.19581849999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001958185	0.19581849999999998
NIEMANN-PICK DISEASE, TYPE A	0.001958185	0.19581849999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001958185	0.19581849999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001958185	0.19581849999999998
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001958185	0.19581849999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.001958185	0.19581849999999998
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001958185	0.19581849999999998
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.001958185	0.19581849999999998
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001958185	0.19581849999999998
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.001958185	0.19581849999999998
DESBUQUOIS DYSPLASIA 1	0.001958185	0.19581849999999998
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001958185	0.19581849999999998
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001958185	0.19581849999999998
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001958185	0.19581849999999998
OSTEOPENIA AND SPARSE HAIR	0.001958185	0.19581849999999998
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.001958185	0.19581849999999998
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001958185	0.19581849999999998
PRIMROSE SYNDROME; PRIMS	0.001958185	0.19581849999999998
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.001958185	0.19581849999999998
PEROXISOME BIOGENESIS DISORDER 3B	0.001958185	0.19581849999999998
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001958185	0.19581849999999998
Mental retardation, autosomal dominant 21	0.001958185	0.19581849999999998
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.001958185	0.19581849999999998
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.001958185	0.19581849999999998
JOUBERT SYNDROME 21	0.001958185	0.19581849999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001958185	0.19581849999999998
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.001958185	0.19581849999999998
JACOBSEN SYNDROME	0.001958185	0.19581849999999998
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001958185	0.19581849999999998
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.001958185	0.19581849999999998
JOUBERT SYNDROME 7	0.001958185	0.19581849999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.001958185	0.19581849999999998
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.001958185	0.19581849999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001958185	0.19581849999999998
JOUBERT SYNDROME 28	0.001958185	0.19581849999999998
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001958185	0.19581849999999998
SOTOS SYNDROME 2	0.001958185	0.19581849999999998
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001958185	0.19581849999999998
JOHANSON-BLIZZARD SYNDROME; JBS	0.001958185	0.19581849999999998
SPINOCEREBELLAR ATAXIA 13	0.001958185	0.19581849999999998
LESCH-NYHAN SYNDROME; LNS	0.001958185	0.19581849999999998
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.001958185	0.19581849999999998
OPTIC ATROPHY 11; OPA11	0.001958185	0.19581849999999998
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.001958185	0.19581849999999998
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.001958185	0.19581849999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001958185	0.19581849999999998
CHROMOSOME 9P DELETION SYNDROME	0.001958185	0.19581849999999998
GALACTOSE EPIMERASE DEFICIENCY	0.001958185	0.19581849999999998
JOUBERT SYNDROME 5	0.001958185	0.19581849999999998
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.001958185	0.19581849999999998
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001958185	0.19581849999999998
WARBURG MICRO SYNDROME 1	0.001958185	0.19581849999999998
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.001958185	0.19581849999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001958185	0.19581849999999998
MUCOLIPIDOSIS IV; ML4	0.001958185	0.19581849999999998
SIFRIM-HITZ-WEISS SYNDROME	0.001958185	0.19581849999999998
GOLDBERG-SHPRINTZEN SYNDROME	0.001958185	0.19581849999999998
JOUBERT SYNDROME 27	0.001958185	0.19581849999999998
HAREL-YOON SYNDROME; HAYOS	0.001958185	0.19581849999999998
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.0017603459999999999	0.17603459999999999
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.0017603459999999999	0.17603459999999999
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0017603459999999999	0.17603459999999999
INCONTINENTIA PIGMENTI; IP	0.0017603459999999999	0.17603459999999999
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0017603459999999999	0.17603459999999999
KIFAFA SEIZURE DISORDER	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED 72	0.0017603459999999999	0.17603459999999999
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.0017603459999999999	0.17603459999999999
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0017603459999999999	0.17603459999999999
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.0017603459999999999	0.17603459999999999
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0017603459999999999	0.17603459999999999
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.0017603459999999999	0.17603459999999999
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.0017603459999999999	0.17603459999999999
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.0017603459999999999	0.17603459999999999
LOWE OCULOCEREBRORENAL SYNDROME	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.0017603459999999999	0.17603459999999999
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0017603459999999999	0.17603459999999999
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.0017603459999999999	0.17603459999999999
GAPO SYNDROME; GAPOS	0.0017603459999999999	0.17603459999999999
POTOCKI-SHAFFER SYNDROME	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, FRA12A TYPE	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.0017603459999999999	0.17603459999999999
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0017603459999999999	0.17603459999999999
HYPERLEUCINE-ISOLEUCINEMIA	0.0017603459999999999	0.17603459999999999
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.0017603459999999999	0.17603459999999999
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.0017603459999999999	0.17603459999999999
GURRIERI SYNDROME	0.0017603459999999999	0.17603459999999999
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.0017603459999999999	0.17603459999999999
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0017603459999999999	0.17603459999999999
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.0017603459999999999	0.17603459999999999
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0017603459999999999	0.17603459999999999
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.0017603459999999999	0.17603459999999999
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.0017603459999999999	0.17603459999999999
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.0017603459999999999	0.17603459999999999
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.0017603459999999999	0.17603459999999999
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.0017603459999999999	0.17603459999999999
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.0017603459999999999	0.17603459999999999
Wolf-Hirschhorn Syndrome	0.0017603459999999999	0.17603459999999999
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0017603459999999999	0.17603459999999999
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.0017603459999999999	0.17603459999999999
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.0017603459999999999	0.17603459999999999
AUTISM	0.0017603459999999999	0.17603459999999999
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0017603459999999999	0.17603459999999999
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.0017603459999999999	0.17603459999999999
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.0017603459999999999	0.17603459999999999
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.0017603459999999999	0.17603459999999999
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.0017603459999999999	0.17603459999999999
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.0017603459999999999	0.17603459999999999
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0017603459999999999	0.17603459999999999
COCKAYNE SYNDROME A; CSA	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.0017603459999999999	0.17603459999999999
COFFIN-SIRIS SYNDROME 5	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.0017603459999999999	0.17603459999999999
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.0017603459999999999	0.17603459999999999
#613707 LEOPARD SYNDROME 3; LPRD3	0.0017603459999999999	0.17603459999999999
HYPERLYSINEMIA, TYPE I	0.0017603459999999999	0.17603459999999999
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0017603459999999999	0.17603459999999999
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0017603459999999999	0.17603459999999999
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0017603459999999999	0.17603459999999999
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.0017603459999999999	0.17603459999999999
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0017603459999999999	0.17603459999999999
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0017603459999999999	0.17603459999999999
CROUZON SYNDROME	0.0017603459999999999	0.17603459999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED 82	0.0017603459999999999	0.17603459999999999
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.0017603459999999999	0.17603459999999999
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.0017603459999999999	0.17603459999999999
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.0017603459999999999	0.17603459999999999
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0017603459999999999	0.17603459999999999
CHROMOSOME 2q37 DELETION SYNDROME	0.0017603459999999999	0.17603459999999999
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.0017603459999999999	0.17603459999999999
GLYCEROL KINASE DEFICIENCY; GKD	0.0017603459999999999	0.17603459999999999
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.0017603459999999999	0.17603459999999999
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0017603459999999999	0.17603459999999999
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.0017603459999999999	0.17603459999999999
RAMON SYNDROME	0.0017603459999999999	0.17603459999999999
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0017603459999999999	0.17603459999999999
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.0017603459999999999	0.17603459999999999
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.0017603459999999999	0.17603459999999999
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.0017603459999999999	0.17603459999999999
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.0017603459999999999	0.17603459999999999
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.0017603459999999999	0.17603459999999999
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.0017603459999999999	0.17603459999999999
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0017603459999999999	0.17603459999999999
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.0017603459999999999	0.17603459999999999
LANDAU-KLEFFNER SYNDROME	0.0017603459999999999	0.17603459999999999
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.0017603459999999999	0.17603459999999999
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0017603459999999999	0.17603459999999999
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0017603459999999999	0.17603459999999999
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.0017603459999999999	0.17603459999999999
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.0017603459999999999	0.17603459999999999
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0017603459999999999	0.17603459999999999
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED 100	0.0017603459999999999	0.17603459999999999
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.0017603459999999999	0.17603459999999999
SJOGREN-LARSSON SYNDROME; SLS	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0017603459999999999	0.17603459999999999
KBG SYNDROME	0.0017603459999999999	0.17603459999999999
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.0017603459999999999	0.17603459999999999
LISSENCEPHALY 1; LIS1	0.0017603459999999999	0.17603459999999999
1p36 microdeletion syndrome	0.0017603459999999999	0.17603459999999999
EPILEPSY-TELANGIECTASIA	0.0017603459999999999	0.17603459999999999
BARAITSER-WINTER SYNDROME 2; BRWS2	0.0017603459999999999	0.17603459999999999
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.0017603459999999999	0.17603459999999999
224250 DYSMYELINATION WITH JAUNDICE	0.0017603459999999999	0.17603459999999999
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0017603459999999999	0.17603459999999999
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.0017603459999999999	0.17603459999999999
PHENYLKETONURIA	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED 103	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.0017603459999999999	0.17603459999999999
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.0017603459999999999	0.17603459999999999
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0017603459999999999	0.17603459999999999
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.0017603459999999999	0.17603459999999999
PAPILLORENAL SYNDROME	0.0017603459999999999	0.17603459999999999
Angelman syndrome (Type 2)	0.0017603459999999999	0.17603459999999999
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.0017603459999999999	0.17603459999999999
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.0017603459999999999	0.17603459999999999
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.0017603459999999999	0.17603459999999999
TUBEROUS SCLEROSIS	0.0017603459999999999	0.17603459999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.0017603459999999999	0.17603459999999999
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0017603459999999999	0.17603459999999999
Angelman syndrome (Type 1)	0.0017603459999999999	0.17603459999999999
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.0017603459999999999	0.17603459999999999
FRYNS SYNDROME; FRNS	0.0017603459999999999	0.17603459999999999
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0017603459999999999	0.17603459999999999
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0017603459999999999	0.17603459999999999
Cerebral creatine deficiency syndrome 2	0.0017603459999999999	0.17603459999999999
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.0017603459999999999	0.17603459999999999
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.0017603459999999999	0.17603459999999999
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.0017603459999999999	0.17603459999999999
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.0017603459999999999	0.17603459999999999
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0017603459999999999	0.17603459999999999
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.0017603459999999999	0.17603459999999999
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.0017603459999999999	0.17603459999999999
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0017603459999999999	0.17603459999999999
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0017603459999999999	0.17603459999999999
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.0017603459999999999	0.17603459999999999
Pierpont syndrome	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.0017603459999999999	0.17603459999999999
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0017603459999999999	0.17603459999999999
TUBEROUS SCLEROSIS 2; TSC2	0.0017603459999999999	0.17603459999999999
CITRULLINEMIA, CLASSIC	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.0017603459999999999	0.17603459999999999
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0017603459999999999	0.17603459999999999
STURGE-WEBER SYNDROME	0.0017603459999999999	0.17603459999999999
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.0017603459999999999	0.17603459999999999
LISSENCEPHALY, X-LINKED, 1; LISX1	0.0017603459999999999	0.17603459999999999
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.0017603459999999999	0.17603459999999999
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.0017603459999999999	0.17603459999999999
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.0017603459999999999	0.17603459999999999
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0017603459999999999	0.17603459999999999
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.0017603459999999999	0.17603459999999999
SUPRABULBAR PARESIS, CONGENITAL	0.0017603459999999999	0.17603459999999999
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.0017603459999999999	0.17603459999999999
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.0017603459999999999	0.17603459999999999
CROME SYNDROME	0.0017603459999999999	0.17603459999999999
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.0017603459999999999	0.17603459999999999
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.0017603459999999999	0.17603459999999999
611961 STEVENSON-CAREY SYNDROME	0.0017603459999999999	0.17603459999999999
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0017603459999999999	0.17603459999999999
ICHTHYOSIS AND MALE HYPOGONADISM	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED 88	0.0017603459999999999	0.17603459999999999
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0017603459999999999	0.17603459999999999
FOUNTAIN SYNDROME	0.0017603459999999999	0.17603459999999999
LISSENCEPHALY 8; LIS8	0.0017603459999999999	0.17603459999999999
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0017603459999999999	0.17603459999999999
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0017603459999999999	0.17603459999999999
AYME-GRIPP SYNDROME; AYGRP	0.0017603459999999999	0.17603459999999999
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.0017603459999999999	0.17603459999999999
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.0017603459999999999	0.17603459999999999
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.0017603459999999999	0.17603459999999999
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0017603459999999999	0.17603459999999999
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.0017603459999999999	0.17603459999999999
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.0017603459999999999	0.17603459999999999
HYPERPROLINEMIA, TYPE II	0.0017603459999999999	0.17603459999999999
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.0017603459999999999	0.17603459999999999
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.0017603459999999999	0.17603459999999999
WAISMAN SYNDROME; WSMN	0.0017603459999999999	0.17603459999999999
FILIPPI SYNDROME; FLPIS	0.0017603459999999999	0.17603459999999999
IMMUNODEFICIENCY 47	0.0017603459999999999	0.17603459999999999
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.0017603459999999999	0.17603459999999999
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0017603459999999999	0.17603459999999999
Myhre syndrome	0.0017603459999999999	0.17603459999999999
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.0017603459999999999	0.17603459999999999
15q13.3 microdeletion syndrome	0.0017603459999999999	0.17603459999999999
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, X-LINKED 96; MRX96	0.0017603459999999999	0.17603459999999999
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.0017603459999999999	0.17603459999999999
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.0017603459999999999	0.17603459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0017603459999999999	0.17603459999999999
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0017603459999999999	0.17603459999999999
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0017603459999999999	0.17603459999999999
OCULOCEREBROCUTANEOUS SYNDROME	0.0017603459999999999	0.17603459999999999
ARGININOSUCCINIC ACIDURIA	0.0017603459999999999	0.17603459999999999
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0017603459999999999	0.17603459999999999
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0017603459999999999	0.17603459999999999
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00111359	0.111359
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00111359	0.111359
JOUBERT SYNDROME 14	0.00111359	0.111359
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00111359	0.111359
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.00111359	0.111359
CEREBELLAR HYPOPLASIA	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00111359	0.111359
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00111359	0.111359
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00111359	0.111359
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00111359	0.111359
SPINOCEREBELLAR ATAXIA 5; SCA5	0.00111359	0.111359
SPINOCEREBELLAR ATAXIA 1	0.00111359	0.111359
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00111359	0.111359
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.00111359	0.111359
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.00111359	0.111359
SENGERS SYNDROME	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.00111359	0.111359
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00111359	0.111359
CAMPOMELIC DYSPLASIA	0.00111359	0.111359
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00111359	0.111359
COMBINED SAPOSIN DEFICIENCY	0.00111359	0.111359
SHPRINTZEN OMPHALOCELE SYNDROME	0.00111359	0.111359
Mulchandani-Bhoj-Conlin syndrome	0.00111359	0.111359
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00111359	0.111359
CHIARI MALFORMATION TYPE II	0.00111359	0.111359
ACID PHOSPHATASE DEFICIENCY	0.00111359	0.111359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.00111359	0.111359
RITSCHER-SCHINZEL SYNDROME 1	0.00111359	0.111359
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00111359	0.111359
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00111359	0.111359
GENITOPATELLAR SYNDROME; GTPTS	0.00111359	0.111359
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00111359	0.111359
CRANIOSYNOSTOSIS 6; CRS6	0.00111359	0.111359
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00111359	0.111359
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00111359	0.111359
PEROXISOME BIOGENESIS DISORDER 6B	0.00111359	0.111359
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00111359	0.111359
GLYCOGEN STORAGE DISEASE IV	0.00111359	0.111359
GLYCOGEN STORAGE DISEASE IXC	0.00111359	0.111359
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00111359	0.111359
OPSISMODYSPLASIA; OPSMD	0.00111359	0.111359
PEROXISOME BIOGENESIS DISORDER 10B	0.00111359	0.111359
NOONAN SYNDROME 11; NS11	0.00111359	0.111359
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00111359	0.111359
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.00111359	0.111359
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00111359	0.111359
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00111359	0.111359
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00111359	0.111359
STUVE-WIEDEMANN SYNDROME	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.00111359	0.111359
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.00111359	0.111359
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00111359	0.111359
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00111359	0.111359
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00111359	0.111359
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.00111359	0.111359
PEROXISOME BIOGENESIS DISORDER 5B	0.00111359	0.111359
SCHOLTE SYNDROME; SHLTS	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.00111359	0.111359
MYOTONIC DYSTROPHY 1	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00111359	0.111359
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00111359	0.111359
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.00111359	0.111359
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00111359	0.111359
MICROPHTHALMIA, SYNDROMIC 3	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00111359	0.111359
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00111359	0.111359
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00111359	0.111359
JOUBERT SYNDROME 31; JBTS31	0.00111359	0.111359
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00111359	0.111359
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00111359	0.111359
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00111359	0.111359
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00111359	0.111359
HYPOTONIA-CYSTINURIA SYNDROME	0.00111359	0.111359
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00111359	0.111359
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00111359	0.111359
ETHANOLAMINOSIS	0.00111359	0.111359
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00111359	0.111359
CHITAYAT SYNDROME	0.00111359	0.111359
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00111359	0.111359
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00111359	0.111359
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00111359	0.111359
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00111359	0.111359
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.00111359	0.111359
PSEUDOTRISOMY 13 SYNDROME	0.00111359	0.111359
CHROMOSOME 4q21 DELETION SYNDROME	0.00111359	0.111359
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00111359	0.111359
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.00111359	0.111359
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00111359	0.111359
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00111359	0.111359
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00111359	0.111359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00111359	0.111359
EPILEPSY, HOT WATER, 1	0.00111359	0.111359
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00111359	0.111359
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00111359	0.111359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00111359	0.111359
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.00111359	0.111359
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.00111359	0.111359
ARIMA SYNDROME	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.00111359	0.111359
JOUBERT SYNDROME 24	0.00111359	0.111359
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00111359	0.111359
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00111359	0.111359
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00111359	0.111359
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.00111359	0.111359
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.00111359	0.111359
DYSTONIA 11, MYOCLONIC	0.00111359	0.111359
PIERSON SYNDROME	0.00111359	0.111359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00111359	0.111359
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00111359	0.111359
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00111359	0.111359
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00111359	0.111359
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00111359	0.111359
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00111359	0.111359
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00111359	0.111359
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00111359	0.111359
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00111359	0.111359
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00111359	0.111359
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00111359	0.111359
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00111359	0.111359
FONTAINE PROGEROID SYNDROME; FPS	0.00111359	0.111359
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00111359	0.111359
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00111359	0.111359
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00111359	0.111359
MEVALONIC ACIDURIA; MEVA	0.00111359	0.111359
NAVAJO NEUROHEPATOPATHY	0.00111359	0.111359
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00111359	0.111359
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00111359	0.111359
JOUBERT SYNDROME 26	0.00111359	0.111359
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00111359	0.111359
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00111359	0.111359
BETHLEM MYOPATHY 2; BTHLM2	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.00111359	0.111359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00111359	0.111359
CRANIOFRONTONASAL SYNDROME; CFNS	0.00111359	0.111359
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00111359	0.111359
NOONAN SYNDROME 6; NS6	0.00111359	0.111359
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00111359	0.111359
AICARDI SYNDROME; AIC	0.00111359	0.111359
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00111359	0.111359
GLYCOGEN STORAGE DISEASE II	0.00111359	0.111359
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00111359	0.111359
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00111359	0.111359
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00111359	0.111359
YOU-HOOVER-FONG SYNDROME; YHFS	0.00111359	0.111359
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00111359	0.111359
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00111359	0.111359
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00111359	0.111359
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00111359	0.111359
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00111359	0.111359
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.00111359	0.111359
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00111359	0.111359
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.00111359	0.111359
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00111359	0.111359
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00111359	0.111359
JOUBERT SYNDROME 25	0.00111359	0.111359
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00111359	0.111359
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00111359	0.111359
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00111359	0.111359
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00111359	0.111359
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00111359	0.111359
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00111359	0.111359
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00111359	0.111359
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00111359	0.111359
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00111359	0.111359
DIAPHANOSPONDYLODYSOSTOSIS	0.00111359	0.111359
PEROXISOME BIOGENESIS DISORDER 11B	0.00111359	0.111359
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00111359	0.111359
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.00111359	0.111359
VERVERI-BRADY SYNDROME; VERBRAS	0.00111359	0.111359
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.00111359	0.111359
GLYCOGEN STORAGE DISEASE IXB	0.00111359	0.111359
JOUBERT SYNDROME 35; JBTS35	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00111359	0.111359
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00111359	0.111359
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00111359	0.111359
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00111359	0.111359
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.00111359	0.111359
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00111359	0.111359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00111359	0.111359
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00111359	0.111359
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00111359	0.111359
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00111359	0.111359
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00111359	0.111359
AL-RAQAD SYNDROME; ARS	0.00111359	0.111359
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00111359	0.111359
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00111359	0.111359
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00111359	0.111359
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00111359	0.111359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00111359	0.111359
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.00111359	0.111359
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.00111359	0.111359
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00111359	0.111359
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00111359	0.111359
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00111359	0.111359
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00111359	0.111359
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00111359	0.111359
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.00111359	0.111359
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00111359	0.111359
PORPHYRIA, ACUTE HEPATIC	0.00111359	0.111359
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00111359	0.111359
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00111359	0.111359
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00111359	0.111359
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00111359	0.111359
LIVER FAILURE, INFANTILE, TRANSIENT	0.00111359	0.111359
JOUBERT SYNDROME 4	0.00111359	0.111359
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00111359	0.111359
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00111359	0.111359
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00111359	0.111359
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00111359	0.111359
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.0915751
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000915751	0.0915751
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.000915751	0.0915751
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.000915751	0.0915751
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.0915751
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000915751	0.0915751
SNEDDON SYNDROME	0.000915751	0.0915751
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000915751	0.0915751
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.000915751	0.0915751
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.0915751
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000915751	0.0915751
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.0915751
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000915751	0.0915751
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.0915751
ALEXANDER DISEASE	0.000915751	0.0915751
KEUTEL SYNDROME; KTLS	0.000915751	0.0915751
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000915751	0.0915751
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000915751	0.0915751
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000915751	0.0915751
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.0915751
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.0915751
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.000915751	0.0915751
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.000915751	0.0915751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.000915751	0.0915751
DARIER-WHITE DISEASE; DAR	0.000915751	0.0915751
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.000915751	0.0915751
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.0915751
Adrenoleukodystrophy	0.000915751	0.0915751
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.0915751
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000915751	0.0915751
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000915751	0.0915751
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.0915751
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000915751	0.0915751
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000915751	0.0915751
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000915751	0.0915751
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.0915751
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000915751	0.0915751
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.0915751
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.0915751
PALLISTER-HALL SYNDROME	0.000915751	0.0915751
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.0915751
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.0915751
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.0915751
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.0915751
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.0915751
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.0915751
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.0915751
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.0915751
THREONINEMIA	0.000915751	0.0915751
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000915751	0.0915751
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.0915751
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.0915751
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000915751	0.0915751
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.0915751
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.0915751
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.0915751
DIAMINOPENTANURIA	0.000915751	0.0915751
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.0915751
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.0915751
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.0915751
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000915751	0.0915751
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.0915751
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000915751	0.0915751
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.0915751
HOLOPROSENCEPHALY 7	0.000915751	0.0915751
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.0915751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000915751	0.0915751
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000915751	0.0915751
PERRAULT SYNDROME 3	0.000915751	0.0915751
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.0915751
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.0915751
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000915751	0.0915751
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000915751	0.0915751
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.0915751
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.0915751
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000915751	0.0915751
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.0915751
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000915751	0.0915751
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.0915751
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000915751	0.0915751
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.000915751	0.0915751
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.0915751
Xq28 (MECP2) duplication	0.000915751	0.0915751
PROPIONIC ACIDEMIA	0.000915751	0.0915751
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000915751	0.0915751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000915751	0.0915751
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.0915751
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.0915751
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.0915751
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.000915751	0.0915751
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.0915751
HYPER-BETA-ALANINEMIA	0.000915751	0.0915751
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.0915751
EPILEPSY, READING	0.000915751	0.0915751
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000915751	0.0915751
KUFOR-RAKEB SYNDROME	0.000915751	0.0915751
#614483 PORENCEPHALY 2; POREN2	0.000915751	0.0915751
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000915751	0.0915751
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000915751	0.0915751
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.0915751
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.0915751
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000915751	0.0915751
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000915751	0.0915751
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.0915751
PARIETAL FORAMINA	0.000915751	0.0915751
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.0915751
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.0915751
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000915751	0.0915751
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.0915751
MACDERMOT-WINTER SYNDROME	0.000915751	0.0915751
CRANIOSYNOSTOSIS 2	0.000915751	0.0915751
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000915751	0.0915751
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.0915751
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.0915751
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.0915751
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.0915751
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000915751	0.0915751
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000915751	0.0915751
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.0915751
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000915751	0.0915751
RETT SYNDROME; RTT	0.000915751	0.0915751
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.0915751
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000915751	0.0915751
MENTAL RETARDATION, X-LINKED 9	0.000915751	0.0915751
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000915751	0.0915751
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.0915751
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.0915751
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000915751	0.0915751
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.0915751
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.0915751
GITELMAN SYNDROME	0.000915751	0.0915751
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000915751	0.0915751
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.0915751
BAND HETEROTOPIA; BH	0.000915751	0.0915751
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.0915751
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.0915751
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.0915751
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000915751	0.0915751
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000915751	0.0915751
PHACE ASSOCIATION	0.000915751	0.0915751
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.0915751
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.000915751	0.0915751
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.0915751
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000915751	0.0915751
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000915751	0.0915751
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.0915751
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000915751	0.0915751
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.0915751
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.0915751
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000915751	0.0915751
GAUCHER DISEASE, TYPE II	0.000915751	0.0915751
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.0915751
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000915751	0.0915751
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.0915751
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.0915751
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.000915751	0.0915751
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.0915751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.0915751
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.0915751
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.0915751
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.0915751
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.0915751
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000915751	0.0915751
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000915751	0.0915751
SECKEL SYNDROME 7; SCKL7	0.000915751	0.0915751
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.0915751
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000915751	0.0915751
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.0915751
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000915751	0.0915751
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.0915751
KRABBE DISEASE	0.000915751	0.0915751
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000915751	0.0915751
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000915751	0.0915751
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.0915751
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.0915751
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.0915751
#602398 DESMOSTEROLOSIS	0.000915751	0.0915751
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.0915751
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.0915751
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.0915751
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.0915751
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000915751	0.0915751
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.0915751
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.0915751
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000915751	0.0915751
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.0915751
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.0915751
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.0915751
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000915751	0.0915751
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000915751	0.0915751
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000915751	0.0915751
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.0915751
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000915751	0.0915751
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.0915751
RETT SYNDROME, CONGENITAL VARIANT	0.000915751	0.0915751
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.0915751
FLYNN-AIRD SYNDROME	0.000915751	0.0915751
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000915751	0.0915751
Fabry disease	0.000915751	0.0915751
CHROMOSOME 19p13.13 DELETION SYNDROME	0.000915751	0.0915751
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.0915751
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.0915751
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000915751	0.0915751
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000915751	0.0915751
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000915751	0.0915751
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.0915751
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.0915751
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000915751	0.0915751
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000915751	0.0915751
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.0915751
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.0915751
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.0915751
KAPUR-TORIELLO SYNDROME	0.000915751	0.0915751
ALZHEIMER DISEASE 3; AD	0.000915751	0.0915751
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.0915751
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000915751	0.0915751
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.0915751
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.0915751
MIRAGE SYNDROME; MIRAGE	0.000915751	0.0915751
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.0915751
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000915751	0.0915751
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.0915751
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.0915751
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.0915751
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000915751	0.0915751
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.0915751
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.0915751
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.0915751
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.0915751
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.0915751
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.0915751
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.0915751
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000915751	0.0915751
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000915751	0.0915751
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000915751	0.0915751
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000915751	0.0915751
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.0915751
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000915751	0.0915751
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.0915751
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.0915751
HHHH SYNDROME	0.000915751	0.0915751
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000915751	0.0915751
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.0915751
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000915751	0.0915751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000915751	0.0915751
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.0915751
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.0915751
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000915751	0.0915751
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000915751	0.0915751
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.0915751
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.0915751
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000915751	0.0915751
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000915751	0.0915751
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000915751	0.0915751
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.0915751
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000915751	0.0915751
THYROCEREBRORETINAL SYNDROME	0.000915751	0.0915751
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.0915751
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.0915751
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.0915751
LISSENCEPHALY 4	0.000915751	0.0915751
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.0915751
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.0915751
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.000915751	0.0915751
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.0915751
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.0915751
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.0915751
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.0915751
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000915751	0.0915751
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.0915751
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.0915751
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.0915751
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.000915751	0.0915751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000915751	0.0915751
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.000915751	0.0915751
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000915751	0.0915751
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.0915751
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000915751	0.0915751
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000915751	0.0915751
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000915751	0.0915751
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.0915751
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.0915751
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.0915751
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000915751	0.0915751
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000915751	0.0915751
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.0915751
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.0915751
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.0915751
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000915751	0.0915751
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.0915751
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.0915751
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000915751	0.0915751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.0915751
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.0915751
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000915751	0.0915751
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000915751	0.0915751
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000915751	0.0915751
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000915751	0.0915751
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000915751	0.0915751
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000915751	0.0915751
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.0915751
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000915751	0.0915751
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000915751	0.0915751
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.0915751
OCULOECTODERMAL SYNDROME; OES	0.000915751	0.0915751
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.0915751
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.0915751
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.0915751
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.0915751
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.0915751
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.0915751
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.0915751
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000915751	0.0915751
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.0915751
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.0915751
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.0915751
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000915751	0.0915751
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000915751	0.0915751
HUNTINGTON DISEASE; HD	0.000915751	0.0915751
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.0915751
HARTNUP DISORDER	0.000915751	0.0915751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000915751	0.0915751
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.0915751
VAN DEN BOSCH SYNDROME	0.000844595	0.08445949999999999
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000844595	0.08445949999999999
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.000844595	0.08445949999999999
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.000844595	0.08445949999999999
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.000844595	0.08445949999999999
HOMOCARNOSINOSIS	0.000844595	0.08445949999999999
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000844595	0.08445949999999999
LARYNGEAL ABDUCTOR PARALYSIS	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 4; BBS4	0.000844595	0.08445949999999999
LOWRY-MACLEAN SYNDROME	0.000844595	0.08445949999999999
WAGR 11p13 deletion syndrome	0.000844595	0.08445949999999999
T-SUBSTANCE ANOMALY	0.000844595	0.08445949999999999
LYSINE MALABSORPTION SYNDROME	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 7; BBS7	0.000844595	0.08445949999999999
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000844595	0.08445949999999999
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.000844595	0.08445949999999999
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.000844595	0.08445949999999999
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.000844595	0.08445949999999999
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000844595	0.08445949999999999
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000844595	0.08445949999999999
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.000844595	0.08445949999999999
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.000844595	0.08445949999999999
HYPOCHONDROPLASIA	0.000844595	0.08445949999999999
FETAL IODINE DEFICIENCY DISORDER	0.000844595	0.08445949999999999
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.000844595	0.08445949999999999
HYDROXYKYNURENINURIA	0.000844595	0.08445949999999999
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.000844595	0.08445949999999999
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.000844595	0.08445949999999999
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000844595	0.08445949999999999
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000844595	0.08445949999999999
245800 LAURENCE-MOON SYNDROME	0.000844595	0.08445949999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.000844595	0.08445949999999999
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000844595	0.08445949999999999
ALPHA-METHYLACETOACETIC ACIDURIA	0.000844595	0.08445949999999999
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.000844595	0.08445949999999999
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.000844595	0.08445949999999999
3q29 microdeletion syndrome	0.000844595	0.08445949999999999
EDINBURGH MALFORMATION SYNDROME	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA 16, X-LINKED	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 23	0.000844595	0.08445949999999999
MICROPHTHALMIA, SYNDROMIC 4	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 84	0.000844595	0.08445949999999999
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000844595	0.08445949999999999
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.000844595	0.08445949999999999
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.000844595	0.08445949999999999
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.000844595	0.08445949999999999
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000844595	0.08445949999999999
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000844595	0.08445949999999999
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.000844595	0.08445949999999999
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000844595	0.08445949999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.000844595	0.08445949999999999
MACROCEPHALY/AUTISM SYNDROME	0.000844595	0.08445949999999999
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.000844595	0.08445949999999999
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.000844595	0.08445949999999999
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.000844595	0.08445949999999999
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000844595	0.08445949999999999
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.000844595	0.08445949999999999
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000844595	0.08445949999999999
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.000844595	0.08445949999999999
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000844595	0.08445949999999999
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000844595	0.08445949999999999
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000844595	0.08445949999999999
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.000844595	0.08445949999999999
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.000844595	0.08445949999999999
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.000844595	0.08445949999999999
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 63	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.000844595	0.08445949999999999
BETA-UREIDOPROPIONASE DEFICIENCY	0.000844595	0.08445949999999999
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.000844595	0.08445949999999999
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.000844595	0.08445949999999999
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000844595	0.08445949999999999
LEBER CONGENITAL AMAUROSIS, TYPE II	0.000844595	0.08445949999999999
GERODERMA OSTEODYSPLASTICUM; GO	0.000844595	0.08445949999999999
MICROPHTHALMIA, SYNDROMIC 12	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 14; BBS14	0.000844595	0.08445949999999999
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.000844595	0.08445949999999999
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000844595	0.08445949999999999
22q11.2 distal deletion syndrome	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 105; MRX105	0.000844595	0.08445949999999999
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.000844595	0.08445949999999999
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.000844595	0.08445949999999999
MECKEL SYNDROME 13; MKS13	0.000844595	0.08445949999999999
RODRIGUES BLINDNESS	0.000844595	0.08445949999999999
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.000844595	0.08445949999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000844595	0.08445949999999999
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.000844595	0.08445949999999999
Cerebral creatine deficiency syndrome 3	0.000844595	0.08445949999999999
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000844595	0.08445949999999999
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000844595	0.08445949999999999
CHROMOSOME Xp11.3 DELETION SYNDROME	0.000844595	0.08445949999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.000844595	0.08445949999999999
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.000844595	0.08445949999999999
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.000844595	0.08445949999999999
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.000844595	0.08445949999999999
GRANGE SYNDROME; GRNG	0.000844595	0.08445949999999999
CHANARIN-DORFMAN SYNDROME	0.000844595	0.08445949999999999
CAHMR SYNDROME	0.000844595	0.08445949999999999
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.000844595	0.08445949999999999
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000844595	0.08445949999999999
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.000844595	0.08445949999999999
WOODHOUSE-SAKATI SYNDROME	0.000844595	0.08445949999999999
SACCHAROPINURIA	0.000844595	0.08445949999999999
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.000844595	0.08445949999999999
GALACTOSEMIA	0.000844595	0.08445949999999999
MEGALENCEPHALY	0.000844595	0.08445949999999999
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.000844595	0.08445949999999999
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.000844595	0.08445949999999999
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 20	0.000844595	0.08445949999999999
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.000844595	0.08445949999999999
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.000844595	0.08445949999999999
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000844595	0.08445949999999999
BASAL CELL NEVUS SYNDROME	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000844595	0.08445949999999999
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000844595	0.08445949999999999
BIEMOND SYNDROME II	0.000844595	0.08445949999999999
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.000844595	0.08445949999999999
CHARGE SYNDROME	0.000844595	0.08445949999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.000844595	0.08445949999999999
3MC SYNDROME 2	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.000844595	0.08445949999999999
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000844595	0.08445949999999999
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.000844595	0.08445949999999999
Rothmund-Thomson syndrome	0.000844595	0.08445949999999999
9q subtelomeric deletion syndrome	0.000844595	0.08445949999999999
HISTIDINEMIA	0.000844595	0.08445949999999999
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.000844595	0.08445949999999999
TYROSINE TRANSAMINASE DEFICIENCY	0.000844595	0.08445949999999999
CHYLOMICRON RETENTION DISEASE	0.000844595	0.08445949999999999
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000844595	0.08445949999999999
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000844595	0.08445949999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000844595	0.08445949999999999
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000844595	0.08445949999999999
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000844595	0.08445949999999999
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.000844595	0.08445949999999999
3MC SYNDROME 3	0.000844595	0.08445949999999999
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.000844595	0.08445949999999999
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000844595	0.08445949999999999
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000844595	0.08445949999999999
FRONTONASAL DYSPLASIA 1; FND1	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.000844595	0.08445949999999999
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 46	0.000844595	0.08445949999999999
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.000844595	0.08445949999999999
MCDONOUGH SYNDROME	0.000844595	0.08445949999999999
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000844595	0.08445949999999999
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000844595	0.08445949999999999
COWCHOCK SYNDROME; COWCK	0.000844595	0.08445949999999999
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000844595	0.08445949999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000844595	0.08445949999999999
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.000844595	0.08445949999999999
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000844595	0.08445949999999999
THUMB DEFORMITY AND ALOPECIA	0.000844595	0.08445949999999999
NOONAN SYNDROME 8; NS8	0.000844595	0.08445949999999999
#612900 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	0.000844595	0.08445949999999999
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000844595	0.08445949999999999
SONODA SYNDROME	0.000844595	0.08445949999999999
SECKEL SYNDROME 8; SCKL8	0.000844595	0.08445949999999999
JOUBERT SYNDROME 10	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 95	0.000844595	0.08445949999999999
OROFACIODIGITAL SYNDROME XI; OFD11	0.000844595	0.08445949999999999
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.000844595	0.08445949999999999
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.000844595	0.08445949999999999
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000844595	0.08445949999999999
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.000844595	0.08445949999999999
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000844595	0.08445949999999999
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.000844595	0.08445949999999999
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.000844595	0.08445949999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.000844595	0.08445949999999999
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.000844595	0.08445949999999999
FEINGOLD SYNDROME 2; FGLDS2	0.000844595	0.08445949999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 6; BBS6	0.000844595	0.08445949999999999
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.000844595	0.08445949999999999
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.000844595	0.08445949999999999
CEPHALIN LIPIDOSIS	0.000844595	0.08445949999999999
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.000844595	0.08445949999999999
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.000844595	0.08445949999999999
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000844595	0.08445949999999999
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000844595	0.08445949999999999
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.000844595	0.08445949999999999
Bardet-Biedl syndrome 2	0.000844595	0.08445949999999999
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000844595	0.08445949999999999
DYSAUTONOMIA-LIKE DISORDER	0.000844595	0.08445949999999999
Oliver-McFarlane syndrome	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 92	0.000844595	0.08445949999999999
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000844595	0.08445949999999999
OROFACIODIGITAL SYNDROME V; OFD5	0.000844595	0.08445949999999999
CHROMOSOME 13q14 DELETION SYNDROME	0.000844595	0.08445949999999999
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000844595	0.08445949999999999
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.000844595	0.08445949999999999
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.000844595	0.08445949999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000844595	0.08445949999999999
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.000844595	0.08445949999999999
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.000844595	0.08445949999999999
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000844595	0.08445949999999999
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.000844595	0.08445949999999999
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.000844595	0.08445949999999999
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000844595	0.08445949999999999
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.000844595	0.08445949999999999
ATR-16 syndrome	0.000844595	0.08445949999999999
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.000844595	0.08445949999999999
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.000844595	0.08445949999999999
CYSTEINE PEPTIDURIA	0.000844595	0.08445949999999999
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000844595	0.08445949999999999
CEREBELLOFACIODENTAL SYNDROME	0.000844595	0.08445949999999999
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.000844595	0.08445949999999999
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000844595	0.08445949999999999
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 97; MRX97	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 81	0.000844595	0.08445949999999999
FOCAL DERMAL HYPOPLASIA; FDH	0.000844595	0.08445949999999999
OROFACIODIGITAL SYNDROME III	0.000844595	0.08445949999999999
207790 ARACHNOID CYSTS, INTRACRANIAL	0.000844595	0.08445949999999999
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000844595	0.08445949999999999
15q24 recurrent microdeletion syndrome	0.000844595	0.08445949999999999
DICARBOXYLICAMINO ACIDURIA	0.000844595	0.08445949999999999
DE SANCTIS-CACCHIONE SYNDROME	0.000844595	0.08445949999999999
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.000844595	0.08445949999999999
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000844595	0.08445949999999999
Jawad syndrome	0.000844595	0.08445949999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000844595	0.08445949999999999
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.000844595	0.08445949999999999
22q11 duplication syndrome	0.000844595	0.08445949999999999
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000844595	0.08445949999999999
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.000844595	0.08445949999999999
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000844595	0.08445949999999999
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.000844595	0.08445949999999999
#611093 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7;;MENTAL RETARDATION, AUTOSOMAL RECESSIVE 22; MRT22	0.000844595	0.08445949999999999
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.000844595	0.08445949999999999
DIBASIC AMINO ACIDURIA I	0.000844595	0.08445949999999999
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.000844595	0.08445949999999999
TOWNES-BROCKS SYNDROME 1; TBS1	0.000844595	0.08445949999999999
1q21.1 recurrent microdeletion (susceptibility locus for neurodevelopmental disorders)	0.000844595	0.08445949999999999
ENCEPHALOMALACIA, MULTILOCULAR	0.000844595	0.08445949999999999
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.000844595	0.08445949999999999
ACHALASIA-MICROCEPHALY SYNDROME	0.000844595	0.08445949999999999
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.000844595	0.08445949999999999
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
8p23.1 duplication syndrome	0.000844595	0.08445949999999999
CONE-ROD DYSTROPHY 1; CORD1	0.000844595	0.08445949999999999
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.000844595	0.08445949999999999
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.000844595	0.08445949999999999
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.000844595	0.08445949999999999
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000844595	0.08445949999999999
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.000844595	0.08445949999999999
2p15-16.1 microdeletion syndrome	0.000844595	0.08445949999999999
Smith-Magenis Syndrome	0.000844595	0.08445949999999999
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.000844595	0.08445949999999999
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.000844595	0.08445949999999999
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.000844595	0.08445949999999999
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.000844595	0.08445949999999999
CREE MENTAL RETARDATION SYNDROME	0.000844595	0.08445949999999999
TRYPTOPHANURIA WITH DWARFISM	0.000844595	0.08445949999999999
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000844595	0.08445949999999999
MYOCLONIC-ATONIC EPILEPSY	0.000844595	0.08445949999999999
OCULORENOCEREBELLAR SYNDROME	0.000844595	0.08445949999999999
OLIVER SYNDROME	0.000844595	0.08445949999999999
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000844595	0.08445949999999999
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000844595	0.08445949999999999
BEHR SYNDROME	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 20	0.000844595	0.08445949999999999
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.000844595	0.08445949999999999
TELECANTHUS	0.000844595	0.08445949999999999
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000844595	0.08445949999999999
BRUNNER SYNDROME; BRNRS	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000844595	0.08445949999999999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.000844595	0.08445949999999999
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000844595	0.08445949999999999
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.000844595	0.08445949999999999
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000844595	0.08445949999999999
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.000844595	0.08445949999999999
Williams-Beuren Syndrome (WBS)	0.000844595	0.08445949999999999
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000844595	0.08445949999999999
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.000844595	0.08445949999999999
SCARF SYNDROME	0.000844595	0.08445949999999999
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.000844595	0.08445949999999999
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000844595	0.08445949999999999
MORQUIO SYNDROME C	0.000844595	0.08445949999999999
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000844595	0.08445949999999999
#300706 MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST;;MENTAL RETARDATION AND MACROCEPHALY SYNDROME	0.000844595	0.08445949999999999
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000844595	0.08445949999999999
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.000844595	0.08445949999999999
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000844595	0.08445949999999999
HEMIFACIAL MICROSOMIA	0.000844595	0.08445949999999999
RAHMAN SYNDROME	0.000844595	0.08445949999999999
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.000844595	0.08445949999999999
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000844595	0.08445949999999999
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000844595	0.08445949999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.000844595	0.08445949999999999
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.000844595	0.08445949999999999
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
OCULOPALATOCEREBRAL SYNDROME	0.000844595	0.08445949999999999
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.000844595	0.08445949999999999
BARBER-SAY SYNDROME; BBRSAY	0.000844595	0.08445949999999999
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.000844595	0.08445949999999999
VELOCARDIOFACIAL SYNDROME	0.000844595	0.08445949999999999
MUCOLIPIDOSIS III ALPHA/BETA	0.000844595	0.08445949999999999
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.000844595	0.08445949999999999
NF1-microdeletion syndrome	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000844595	0.08445949999999999
RICHARDS-RUNDLE SYNDROME; RRNS	0.000844595	0.08445949999999999
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000844595	0.08445949999999999
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000844595	0.08445949999999999
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.000844595	0.08445949999999999
MICROCEPHALY-CARDIOMYOPATHY	0.000844595	0.08445949999999999
LAMBERT SYNDROME	0.000844595	0.08445949999999999
FORMIMINOTRANSFERASE DEFICIENCY	0.000844595	0.08445949999999999
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000844595	0.08445949999999999
CHOPS SYNDROME; CHOPS	0.000844595	0.08445949999999999
Prader-Willi syndrome (Type 1)	0.000844595	0.08445949999999999
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.000844595	0.08445949999999999
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000844595	0.08445949999999999
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.000844595	0.08445949999999999
PSEUDOURIDINURIA AND MENTAL DEFECT	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 9; BBS9	0.000844595	0.08445949999999999
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.000844595	0.08445949999999999
Cat-Eye Syndrome (Type I)	0.000844595	0.08445949999999999
#613612 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I;;CDG IIi; CDGIIi	0.000844595	0.08445949999999999
HOOFT DISEASE	0.000844595	0.08445949999999999
16p11.2-p12.2 microdeletion syndrome	0.000844595	0.08445949999999999
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.000844595	0.08445949999999999
17q21.31 recurrent microdeletion syndrome	0.000844595	0.08445949999999999
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.000844595	0.08445949999999999
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 13; BBS13	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 19; BBS19	0.000844595	0.08445949999999999
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000844595	0.08445949999999999
OPTIC ATROPHY 2	0.000844595	0.08445949999999999
2q37 monosomy	0.000844595	0.08445949999999999
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.000844595	0.08445949999999999
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000844595	0.08445949999999999
7q11.23 duplication syndrome	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000844595	0.08445949999999999
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.000844595	0.08445949999999999
GILLESPIE SYNDROME; GLSP	0.000844595	0.08445949999999999
NEPHRONOPHTHISIS 18; NPHP18	0.000844595	0.08445949999999999
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000844595	0.08445949999999999
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.000844595	0.08445949999999999
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.000844595	0.08445949999999999
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000844595	0.08445949999999999
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000844595	0.08445949999999999
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.000844595	0.08445949999999999
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000844595	0.08445949999999999
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.000844595	0.08445949999999999
8p23.1 deletion syndrome	0.000844595	0.08445949999999999
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.000844595	0.08445949999999999
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.000844595	0.08445949999999999
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000844595	0.08445949999999999
PENDRED SYNDROME	0.000844595	0.08445949999999999
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.000844595	0.08445949999999999
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000844595	0.08445949999999999
HYDROXYLYSINURIA	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000844595	0.08445949999999999
SOTOS SYNDROME 3	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 8; BBS8	0.000844595	0.08445949999999999
IMINOGLYCINURIA	0.000844595	0.08445949999999999
FANCONI ANEMIA	0.000844595	0.08445949999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000844595	0.08445949999999999
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 16; BBS16	0.000844595	0.08445949999999999
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.000844595	0.08445949999999999
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000844595	0.08445949999999999
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000844595	0.08445949999999999
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.000844595	0.08445949999999999
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000844595	0.08445949999999999
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000844595	0.08445949999999999
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000844595	0.08445949999999999
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000844595	0.08445949999999999
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000844595	0.08445949999999999
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 53	0.000844595	0.08445949999999999
DEAFNESS AND MYOPIA; DFNMYP	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.000844595	0.08445949999999999
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000844595	0.08445949999999999
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.000844595	0.08445949999999999
LEBER OPTIC ATROPHY AND DYSTONIA	0.000844595	0.08445949999999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000844595	0.08445949999999999
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.000844595	0.08445949999999999
MASA SYNDROME	0.000844595	0.08445949999999999
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000844595	0.08445949999999999
AGENESIS OF CEREBRAL WHITE MATTER	0.000844595	0.08445949999999999
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.000844595	0.08445949999999999
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.000844595	0.08445949999999999
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000844595	0.08445949999999999
12q14 microdeletion syndrome	0.000844595	0.08445949999999999
N SYNDROME	0.000844595	0.08445949999999999
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000844595	0.08445949999999999
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000844595	0.08445949999999999
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000844595	0.08445949999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.000844595	0.08445949999999999
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.000844595	0.08445949999999999
CARNOSINEMIA	0.000844595	0.08445949999999999
Retinitis pigmentosa with or without skeletal anomalies	0.000844595	0.08445949999999999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.000844595	0.08445949999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000844595	0.08445949999999999
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.000844595	0.08445949999999999
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.000844595	0.08445949999999999
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000844595	0.08445949999999999
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000844595	0.08445949999999999
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.000844595	0.08445949999999999
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000844595	0.08445949999999999
FRONTONASAL DYSPLASIA 2; FND2	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000844595	0.08445949999999999
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000844595	0.08445949999999999
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000844595	0.08445949999999999
#614728 SECKEL SYNDROME 6; SCKL6	0.000844595	0.08445949999999999
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000844595	0.08445949999999999
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.000844595	0.08445949999999999
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000844595	0.08445949999999999
#614815 JOUBERT SYNDROME 18; JBTS18	0.000844595	0.08445949999999999
Bangstad syndrome	0.000844595	0.08445949999999999
HYDROXYPROLINEMIA	0.000844595	0.08445949999999999
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000844595	0.08445949999999999
Cri du Chat Syndrome (5p deletion)	0.000844595	0.08445949999999999
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.000844595	0.08445949999999999
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000844595	0.08445949999999999
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000844595	0.08445949999999999
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.000844595	0.08445949999999999
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.000844595	0.08445949999999999
#615328 SHAHEEN SYNDROME; SHNS	0.000844595	0.08445949999999999
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000844595	0.08445949999999999
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000844595	0.08445949999999999
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000844595	0.08445949999999999
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.000844595	0.08445949999999999
Potocki-Shaffer syndrome	0.000844595	0.08445949999999999
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000844595	0.08445949999999999
MENTAL RETARDATION, X-LINKED 77	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000844595	0.08445949999999999
DERMATOLEUKODYSTROPHY	0.000844595	0.08445949999999999
Congenital disorder of glycosylation, type IIh	0.000844595	0.08445949999999999
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000844595	0.08445949999999999
RUVALCABA SYNDROME	0.000844595	0.08445949999999999
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.000844595	0.08445949999999999
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.000844595	0.08445949999999999
1q21.1 recurrent microduplication (possible susceptibility locus for neurodevelopmental disorders)	0.000844595	0.08445949999999999
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.000844595	0.08445949999999999
BARDET-BIEDL SYNDROME 3; BBS3	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000844595	0.08445949999999999
#614249 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18	0.000844595	0.08445949999999999
ELLIS-VAN CREVELD SYNDROME	0.000844595	0.08445949999999999
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.000844595	0.08445949999999999
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000844595	0.08445949999999999
HOLOPROSENCEPHALY 3; HPE3	0.000844595	0.08445949999999999
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000844595	0.08445949999999999
CARDIAC-UROGENITAL SYNDROME; CUGS	0.000844595	0.08445949999999999
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.000844595	0.08445949999999999
FACIOCARDIOMELIC SYNDROME	0.000844595	0.08445949999999999
CHROMOSOME 15Q14 DELETION SYNDROME	0.000844595	0.08445949999999999
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000844595	0.08445949999999999
MEIER-GORLIN SYNDROME 6; MGORS6	0.000844595	0.08445949999999999
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.000844595	0.08445949999999999
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.000844595	0.08445949999999999
#611090 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12	0.000844595	0.08445949999999999
GLUTATHIONURIA	0.000844595	0.08445949999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000844595	0.08445949999999999
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000844595	0.08445949999999999
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.000844595	0.08445949999999999
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000844595	0.08445949999999999
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000844595	0.08445949999999999
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000844595	0.08445949999999999
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.000844595	0.08445949999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.000844595	0.08445949999999999
HURLER SYNDROME	0.000844595	0.08445949999999999
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000844595	0.08445949999999999
NIJMEGEN BREAKAGE SYNDROME	0.000844595	0.08445949999999999
Prader-Willi Syndrome (Type 2)	0.000844595	0.08445949999999999
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.000844595	0.08445949999999999
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.000844595	0.08445949999999999
